Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
respiratory
Pharma
AZ's Breztri picks up 2nd FDA nod, unlocking asthma market
After smashing the blockbuster sales threshold in 2025, AstraZeneca’s three-in-one inhaler Breztri Aerosphere has passed another crucial milestone.
Fraiser Kansteiner
Apr 28, 2026 10:47am
Lupin to lay out $250M for new Fla. manufacturing facility
Oct 9, 2025 9:02am
AstraZeneca hit by marketing breaches for respiratory meds
Mar 20, 2023 9:25am
Roche's rosy pandemic scenario deals a $2B blow to COVID sales
Feb 3, 2022 4:35pm
AstraZeneca, Amgen tap Brand Institute in a new naming twist
Jan 6, 2022 8:20am
GSK reveals health fears of eosinophilic asthma patients
Dec 20, 2021 7:40am
